CPIM
GSK icon

Columbia Partners Investment Management’s GSK GSK Stock Holding History

Columbia Partners Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-25,819
Closed -$1.48M – 341
2014
Q3 		$1.48M Sell
25,819
-33,528
-56% -$2.06M 0.08% 214
2014
Q2 		$3.97M Buy
59,347
+20,165
+51% +$1.36M 0.18% 165
2014
Q1 		$2.62M Sell
39,182
-13,495
-26% -$912K 0.11% 196
2013
Q4 		$3.52M Buy
52,677
+3,023
+6% +$196K 0.15% 168
2013
Q3 		$3.11M Buy
49,654
+8,934
+22% +$575K 0.14% 179
2013
Q2 		$2.54M Buy
+40,720
New +$2.58M 0.12% 201

Other funds holding GSK

LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Columbia Partners Investment Management's GSK Position: Q4 2014 in Review

Columbia Partners Investment Management sold out of GSK (GSK) in Q4 2014, closing a stake of 25,819 shares — an estimated $1.48M sold.

Columbia Partners Investment Management first reported a position in GSK in Q2 2013 and held it in 6 quarters. The position peaked at $3.97M in Q2 2014. 729 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

  • Columbia Partners Investment Management reported no remaining GSK position as of Q4 2014 after selling out during the quarter.
  • Columbia Partners Investment Management sold 25,819 GSK shares in Q4 2014, an estimated $1.48M.
  • Columbia Partners Investment Management first reported a position in GSK in Q2 2013 and held it in 6 quarters.
  • Columbia Partners Investment Management's GSK position peaked at $3.97M in Q2 2014.
  • 729 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on Columbia Partners Investment Management's 13F filing for Q4 2014, filed 11 Feb 2015.